Heart rate as a therapeutic target in heart failure?

被引：10
|
作者：
Tavazzi, L [1 ]
机构：
[1] Inst Care Res, Dept Cardiol, Policlin San Matteo, Pavia, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2003年 / 5卷 / 0G期
关键词：
heart rate; heart failure; I-f channel; I-f channel antagonist; ivabradine;
D O I：
10.1016/S1520-765X(03)90003-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A common finding in all clinical trials on heart failure is a negative correlation between heart rate and duration of life. In several studies this was found in both patients taking and those not taking beta-blocker agents. In postinfarct patients increasing mortality with increasing heart rate was found in the absence and in the presence of left ventricular dysfunction. Moreover beneficial effects of neurohormonal modulators were found to be greater in heart failure patients with higher heart rate. Thus heart rate can be considered a target for medical intervention, and therapeutic attempts focused on direct control of heart rate have a good rationale. (C) 2003 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：G15 / G18
页数：4
相关论文
共 50 条
  • [31] Heart failure: an underestimated therapeutic target in diabetes
    Marx, Nikolaus
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2018, 7 (01): : 10 - 12
  • [32] The interstitial compartment as a therapeutic target in heart failure
    Aronson, Doron
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [33] Mitochondrial function as a therapeutic target in heart failure
    David A. Brown
    Justin B. Perry
    Mitchell E. Allen
    Hani N. Sabbah
    Brian L. Stauffer
    Saame Raza Shaikh
    John G. F. Cleland
    Wilson S. Colucci
    Javed Butler
    Adriaan A. Voors
    Stefan D. Anker
    Bertram Pitt
    Burkert Pieske
    Gerasimos Filippatos
    Stephen J. Greene
    Mihai Gheorghiade
    Nature Reviews Cardiology, 2017, 14 : 238 - 250
  • [34] Vasopressin: A therapeutic target in congestive heart failure?
    Goldsmith, SR
    JOURNAL OF CARDIAC FAILURE, 1999, 5 (04) : 347 - 356
  • [35] Hyperuricemia is a new therapeutic target of heart failure
    Yoshiharu, K
    Kasuhide, O
    Yoko, T
    Masahiko, K
    Shuichi, O
    Toru, K
    Osamu, I
    Ichiro, H
    Chiaki, S
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (05) : S192 - S192
  • [36] Heart Rate as a Therapeutic Target in Angina Pectoris
    Androulakis, Emmanuel
    Tousoulis, Dimitris
    Papageorgiou, Nikolaos
    Kontogeorgou, Anna
    Briasoulis, Alexandros
    Charakida, Marietta
    Siasos, Gerasimos
    Oikonomou, Evangelos
    Siama, Katerina
    Latsios, George
    Stefanadis, Christodoulos
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (09) : 1562 - 1568
  • [37] Heart rate in heart failure with preserved ejection fraction: target or marker?
    Kalogeropoulos, Andreas P.
    Butler, Javed
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (11) : 1504 - 1506
  • [38] How to consider target heart rate in patients with systolic heart failure
    Izumida, Toshihide
    Imamura, Teruhiko
    Nakamura, Makiko
    Fukuda, Nobuyuki
    Kinugawa, Koihciro
    ESC HEART FAILURE, 2020, 7 (05): : 3231 - 3234
  • [39] Impaired energetics in heart failure - A new therapeutic target
    Ormerod, Julian O. M.
    Ashrafian, Houman
    Frenneaux, Michael P.
    PHARMACOLOGY & THERAPEUTICS, 2008, 119 (03) : 264 - 274
  • [40] Anemia as a risk factor and therapeutic target in heart failure
    Felker, GM
    Adams, KF
    Gattis, WA
    O'Connor, CM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (05) : 959 - 966
12345